Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,057 | 12,360 | 11,144 | 25,201 | 29,417 |
| Marketable Securities | 105,569 | 126,980 | 136,115 | 158,747 | 179,048 |
| Receivables | 1,672 | 1,973 | 2,070 | 2,027 | 1,932 |
| Other current assets | 691 | 1,006 | 860 | 753 | 808 |
| TOTAL | $122,381 | $145,232 | $155,506 | $192,506 | $217,323 |
| Non-Current Assets | |||||
| PPE Net | 6,123 | 6,760 | 7,598 | 8,179 | 18,519 |
| Investments And Advances | 1,001 | 3,505 | 12,096 | 132 | 13,252 |
| Other Non-Current Assets | 19,493 | 19,870 | 19,784 | 20,086 | 24,562 |
| TOTAL | $26,617 | $30,135 | $39,478 | $28,397 | $56,333 |
| Total Assets | $148,998 | $175,367 | $194,984 | $220,903 | $273,656 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,503 | 5,783 | 3,804 | 3,243 | 3,873 |
| Accrued Expenses | 13,889 | 16,535 | 19,350 | 20,528 | 19,888 |
| TOTAL | $19,673 | $25,414 | $28,058 | $28,887 | $28,491 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 994 | 1,895 | 2,217 | 2,829 | 2,829 |
| Other Non-Current Liabilities | 25,659 | 26,026 | 22,777 | 23,564 | 24,774 |
| TOTAL | $27,307 | $27,778 | $25,081 | $25,884 | $27,943 |
| Total Liabilities | $46,980 | $53,192 | $53,139 | $54,771 | $56,434 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,181 | 96,637 | 93,468 | 93,123 | 93,005 |
| Common Shares | 10 | 9 | 9 | 9 | 9 |
| Retained earnings | -621,600 | -596,515 | -570,027 | -542,479 | -488,381 |
| Other shareholders' equity | -23 | 103 | 93 | 40 | 167 |
| TOTAL | $102,018 | $122,175 | $141,845 | $166,132 | $217,222 |
| Total Liabilities And Equity | $148,998 | $175,367 | $194,984 | $220,903 | $273,656 |